Pneumococcal vaccination in celiac disease.
Celiac disease
hyposplenism
infections
pneumococcal vaccination
pneumonia
Journal
Expert review of gastroenterology & hepatology
ISSN: 1747-4132
Titre abrégé: Expert Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101278199
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
17
4
2019
medline:
18
12
2019
entrez:
17
4
2019
Statut:
ppublish
Résumé
Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure in genetically predisposed subjects. Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients. Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition in both the general population and celiac patients. Pneumococcal vaccination is the most effective means for its prevention. Expert opinion: In CD, evaluation of spleen function should be useful to select patients who may benefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could be employed: physicians could search for signs of hyposplenism on peripheral blood smear or abdominal ultrasound. However, the best strategy to identify which patients will benefit from pneumococcal vaccination has not yet been defined.
Identifiants
pubmed: 30987472
doi: 10.1080/17474124.2019.1607295
doi:
Substances chimiques
Pneumococcal Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM